Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis

• Main Authors: Edoardo Lenci (Author), Giulia Marcantognini (Author), Valeria Cognigni (Author), Alessio Lupi (Author), Silvia Rinaldi (Author), Luca Cantini (Author), Ilaria Fiordoliva (Author), Anna Lisa Carloni (Author), Marco Rocchi (Author), Lina Zuccatosta (Author), Stefano Gasparini (Author), Rossana Berardi (Author)
• Format: Book
• Published: Open Exploration Publishing Inc., 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim: The role of tumor burden (TB) for patients with non-small cell lung cancer (NSCLC) receiving immunotherapy is still unknown. The aim of this analysis was to analyze the prognostic value of TB in a real-world sample of advanced NSCLC patients. Methods: Sixty-five consecutive patients with advanc...